Now, the Food and Drug Administration is looking to regulate e-cigarettes in America, and the pervasive influence of the legal drug lobby lingers in this regulator's halls like cheap cigar smoke. You can almost smell Big Pharma in the FDA's curtains, and it is understandable. Its very business depends upon FDA decisions, and if big government controls your business, you better be heavily invested in influencing that decision.
That is the problem with big government. Common-
sense things like basic
harm reduction through alternative nicotine delivery systems end up becoming threats to those who have developed different options. Rather than fight it out in the marketplace, it is natural for those who invest hundreds of millions of dollars to influence regulators and elected officials to use this necessary expenditure to create an advantage for their product.
This is the government relations return on investment that every company desires.